Covid-flu joint booster jab possible late 2023: Moderna

The single vaccine for COVID-19, influenza, and respiratory syncytial virus—a common virus that causes the cold, but can be more serious for infants and elderly people—could appear on the market before 2024. “Best-case scenario will be the fall of ’23,” Moderna chief executive Stephane Bancel told a virtual World Economic Forum roundtable session. https://bit.ly/33ruBRS